New Results
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by 4 doses of parental mRNA vaccine or a BA.5-bivalent booster
Chaitanya Kurhade, Jing Zou, Hongjie Xia, Mingru Liu, Hope C. Chang, Ping Ren, View ORCID ProfileXuping Xie, Pei-Yong Shi
doi: https://doi.org/10.1101/2022.10.31.514580
Chaitanya Kurhade
1Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
Jing Zou
1Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
Hongjie Xia
1Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
Mingru Liu
2Department of Pathology, University of Texas Medical Branch, Galveston Texas, USA
Hope C. Chang
2Department of Pathology, University of Texas Medical Branch, Galveston Texas, USA
Ping Ren
2Department of Pathology, University of Texas Medical Branch, Galveston Texas, USA
Xuping Xie
1Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
Pei-Yong Shi
1Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
3Sealy Institute for Drug Discovery, University of Texas Medical Branch, Galveston, TX, USA
4Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA
5Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA
6Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA

- Supplementary Tables 1-3[supplements/514580_file02.docx]
Posted November 02, 2022.
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by 4 doses of parental mRNA vaccine or a BA.5-bivalent booster
Chaitanya Kurhade, Jing Zou, Hongjie Xia, Mingru Liu, Hope C. Chang, Ping Ren, Xuping Xie, Pei-Yong Shi
bioRxiv 2022.10.31.514580; doi: https://doi.org/10.1101/2022.10.31.514580
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by 4 doses of parental mRNA vaccine or a BA.5-bivalent booster
Chaitanya Kurhade, Jing Zou, Hongjie Xia, Mingru Liu, Hope C. Chang, Ping Ren, Xuping Xie, Pei-Yong Shi
bioRxiv 2022.10.31.514580; doi: https://doi.org/10.1101/2022.10.31.514580
Subject Area
Subject Areas
- Biochemistry (10821)
- Bioengineering (8061)
- Bioinformatics (27369)
- Biophysics (14012)
- Cancer Biology (11155)
- Cell Biology (16091)
- Clinical Trials (138)
- Developmental Biology (8806)
- Ecology (13321)
- Epidemiology (2067)
- Evolutionary Biology (17388)
- Genetics (11703)
- Genomics (15955)
- Immunology (11055)
- Microbiology (26147)
- Molecular Biology (10673)
- Neuroscience (56693)
- Paleontology (422)
- Pathology (1737)
- Pharmacology and Toxicology (3012)
- Physiology (4565)
- Plant Biology (9662)
- Synthetic Biology (2697)
- Systems Biology (6991)
- Zoology (1513)